标题
Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 217, Issue 1, Pages -
出版商
Rockefeller University Press
发表日期
2019-11-15
DOI
10.1084/jem.20191123
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Skin Commensal Yeast Malassezia Triggers a Type 17 Response that Coordinates Anti-fungal Immunity and Exacerbates Skin Inflammation
- (2019) Florian Sparber et al. Cell Host & Microbe
- Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials
- (2019) Stefan Schreiber et al. ANNALS OF THE RHEUMATIC DISEASES
- The IL-17 Family of Cytokines in Health and Disease
- (2019) Mandy J. McGeachy et al. IMMUNITY
- Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1β
- (2019) Juliana Komuczki et al. IMMUNITY
- Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials
- (2018) A. Blauvelt et al. BRITISH JOURNAL OF DERMATOLOGY
- Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair
- (2018) Jonathan L. Linehan et al. CELL
- A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases
- (2018) Michael Lyman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ixekizumab provides superior efficacy compared to ustekinumab over 52-weeks of treatment: results from IXORA-S, a phase 3 study
- (2018) Carle Paul et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
- (2018) Atul Deodhar et al. LANCET
- Suppression of IL-17F, but not of IL-17A, provides protection against colitis by inducing Treg cells through modification of the intestinal microbiota
- (2018) Ce Tang et al. NATURE IMMUNOLOGY
- Expression of interleukin-17 in primary Sjögren's syndrome and the correlation with disease severity: A systematic review and meta-analysis
- (2018) L.-W. Zhang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response
- (2018) Philip J. Mease et al. Arthritis & Rheumatology
- The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling
- (2018) Melissa N. van Tok et al. Frontiers in Immunology
- A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It
- (2018) Nicola Tamassia et al. Frontiers in Immunology
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: An integrated analysis from 11 clinical trials
- (2018) R G Langley et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
- (2018) Kenneth B Gordon et al. LANCET
- Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction
- (2018) V. Michael Holers et al. Nature Reviews Rheumatology
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Safety of Ixekizumab in Patients with Psoriatic Arthritis: Results from a Pooled Analysis of Three Clinical Trials
- (2018) Philip Mease et al. ARTHRITIS CARE & RESEARCH
- Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response
- (2018) L.M. Sawyer et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
- (2018) Désirée van der Heijde et al. LANCET
- Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study
- (2017) Bruce E. Sands et al. GASTROENTEROLOGY
- Dysregulation of the Cytokine GM-CSF Induces Spontaneous Phagocyte Invasion and Immunopathology in the Central Nervous System
- (2017) Sabine Spath et al. IMMUNITY
- β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
- (2017) Frank Kolbinger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- CNTO6785, a Fully Human Antiinterleukin 17 Monoclonal Antibody, in Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: A Randomized, Placebo-controlled, Phase II, Dose-ranging Study
- (2017) Philip J. Mease et al. JOURNAL OF RHEUMATOLOGY
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
- (2017) Peter Nash et al. LANCET
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
- (2017) Kristian Reich et al. LANCET
- Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
- (2017) Brian G Feagan et al. LANCET
- Inflammatory memory sensitizes skin epithelial stem cells to tissue damage
- (2017) Shruti Naik et al. NATURE
- Psoriatic Arthritis
- (2017) Christopher T. Ritchlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-17 Signaling: The Yin and the Yang
- (2017) Nilesh Amatya et al. TRENDS IN IMMUNOLOGY
- Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications
- (2017) Leticia Monin et al. Cold Spring Harbor Perspectives in Biology
- Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis
- (2017) Dan Hu et al. Nature Communications
- Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study
- (2017) Francisco J. Blanco et al. Arthritis & Rheumatology
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease
- (2016) Stephan R Targan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
- (2016) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
- (2016) Saakshi Khattri et al. EXPERIMENTAL DERMATOLOGY
- Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation
- (2016) Pawan Kumar et al. IMMUNITY
- Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study
- (2016) Eva Havrdová et al. JOURNAL OF NEUROLOGY
- Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease
- (2016) René Pfeifle et al. NATURE IMMUNOLOGY
- Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
- (2016) Kenneth B. Gordon et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-12 protects from psoriasiform skin inflammation
- (2016) Paulina Kulig et al. Nature Communications
- The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study
- (2016) Lihi Eder et al. Arthritis & Rheumatology
- Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): Association with clinical severity and phenotype
- (2015) Salvatore Leonardi et al. ALLERGY AND ASTHMA PROCEEDINGS
- Th17 Cytokines Regulate Osteoclastogenesis in Rheumatoid Arthritis
- (2015) Kyoung-Woon Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
- (2015) Itay Raphael et al. CYTOKINE
- Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
- (2015) Jacob S. Lee et al. IMMUNITY
- Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage
- (2015) Xinyang Song et al. IMMUNITY
- Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
- (2015) Joseph R. Maxwell et al. IMMUNITY
- Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis
- (2015) Shunya Mashiko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-17A, IL-22, and IL-23 as Markers of Psoriasis Activity
- (2015) Christina Fotiadou et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Psoriatic Inflammation Facilitates the Onset of Arthritis in a Mouse Model
- (2015) Mayuko Yamamoto et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- (2015) K. Pavelka et al. JOURNAL OF RHEUMATOLOGY
- Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis
- (2015) Axel Patrice Villani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
- (2015) Christopher E M Griffiths et al. LANCET
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- Commensal–dendritic-cell interaction specifies a unique protective skin immune signature
- (2015) Shruti Naik et al. NATURE
- Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
- (2015) Dominique Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
- (2015) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
- (2015) Yonghao Cao et al. Science Translational Medicine
- Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis
- (2015) John Bowes et al. Nature Communications
- Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
- (2015) Jennifer Belasco et al. Arthritis & Rheumatology
- Brief Report: Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid
- (2015) Emmerik F. A. Leijten et al. Arthritis & Rheumatology
- Differential Effects of IL-17A and TNF-α on Osteoblastic Differentiation of Isolated Synoviocytes and on Bone Explants from Arthritis Patients
- (2015) Bilal Osta et al. Frontiers in Immunology
- IL-17-Producing Alveolar Macrophages Mediate Allergic Lung Inflammation Related to Asthma
- (2014) C. Song et al. JOURNAL OF IMMUNOLOGY
- Development of Proteoglycan-Induced Arthritis Is Independent of IL-17
- (2014) P. D. Doodes et al. JOURNAL OF IMMUNOLOGY
- Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
- (2014) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Interleukin-17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
- (2014) Bina Menon et al. Arthritis & Rheumatology
- Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
- (2013) William W. Busse et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- IL-17 family: Cytokines, receptors and signaling
- (2013) Chunfang Gu et al. CYTOKINE
- Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis
- (2013) Janosch Katt et al. HEPATOLOGY
- IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions
- (2013) Andrew L. Croxford et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
- (2013) Iain B McInnes et al. LANCET
- Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
- (2013) Noriko Komatsu et al. NATURE MEDICINE
- Neutrophils Are Essential As A Source Of Il-17 In The Effector Phase Of Arthritis
- (2013) Masaki Katayama et al. PLoS One
- B Cells Contribute to Heterogeneity of IL-17 Producing Cells in Rheumatoid Arthritis and Healthy Controls
- (2013) Paul Martin Schlegel et al. PLoS One
- Th17 and Th22 cells in psoriatic arthritis and psoriasis
- (2013) Helen Benham et al. ARTHRITIS RESEARCH & THERAPY
- Human Th17 subsets
- (2012) Federica Sallusto et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
- (2012) Wolfgang Hueber et al. GUT
- Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice
- (2012) Stanislav Pantelyushin et al. JOURNAL OF CLINICAL INVESTIGATION
- Induction and molecular signature of pathogenic TH17 cells
- (2012) Youjin Lee et al. NATURE IMMUNOLOGY
- Psoriasis
- (2011) Gayathri K. Perera et al. Annual Review of Pathology-Mechanisms of Disease
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- IL-17A and IL-17F Expression in B Lymphocytes
- (2011) Alejandro Vazquez-Tello et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Th17 Cells Induce Colitis and Promote Th1 Cell Responses through IL-17 Induction of Innate IL-12 and IL-23 Production
- (2011) T. Feng et al. JOURNAL OF IMMUNOLOGY
- Identification of a Novel Proinflammatory Human Skin-Homing V 9V 2 T Cell Subset with a Potential Role in Psoriasis
- (2011) U. Laggner et al. JOURNAL OF IMMUNOLOGY
- Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
- (2011) A. M. Lin et al. JOURNAL OF IMMUNOLOGY
- Control of TH17 cells occurs in the small intestine
- (2011) Enric Esplugues et al. NATURE
- RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
- (2011) Laura Codarri et al. NATURE IMMUNOLOGY
- The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
- (2011) Mohamed El-Behi et al. NATURE IMMUNOLOGY
- Interleukin-17 and its expanding biological functions
- (2010) Sheng Xu et al. Cellular & Molecular Immunology
- Th17 and Th1 T-Cell Responses in Giant Cell Arteritis
- (2010) Jiusheng Deng et al. CIRCULATION
- Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
- (2010) Philip P. Ahern et al. IMMUNITY
- Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
- (2010) Hsin-Jung Wu et al. IMMUNITY
- Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
- (2010) Reiko M. Onishi et al. IMMUNOLOGY
- IL-6 Promotes NK Cell Production of IL-17 during Toxoplasmosis
- (2010) Sara T. Passos et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis
- (2010) G. Tonel et al. JOURNAL OF IMMUNOLOGY
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing–remitting or secondary progressive multiple sclerosis
- (2010) Timothy L Vollmer et al. Multiple Sclerosis Journal
- Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
- (2010) Sofia Buonocore et al. NATURE
- Modulation of IL-17 and Foxp3 Expression in the Prevention of Autoimmune Arthritis in Mice
- (2010) Joana Duarte et al. PLoS One
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis
- (2009) Yoshinaga Ito et al. ARTHRITIS AND RHEUMATISM
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
- (2009) Ivaylo I. Ivanov et al. CELL
- IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammationin vivo
- (2009) Gabor Gyülvészi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
- (2009) Caroline E. Sutton et al. IMMUNITY
- IL-17 produced by neutrophils regulates IFN-γ–mediated neutrophil migration in mouse kidney ischemia-reperfusion injury
- (2009) Li Li et al. JOURNAL OF CLINICAL INVESTIGATION
- T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
- (2009) Yuhong Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
- (2009) L. van der Fits et al. JOURNAL OF IMMUNOLOGY
- IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
- (2009) Consuelo Ortega et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A protective function for interleukin 17A in T cell–mediated intestinal inflammation
- (2009) William O'Connor Jr et al. NATURE IMMUNOLOGY
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- RORγ-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17F
- (2008) Moritz Leppkes et al. GASTROENTEROLOGY
- Th17 Cell Differentiation: The Long and Winding Road
- (2008) Mandy J. McGeachy et al. IMMUNITY
- IL-23/IL-17 immunity as a hallmark of Crohnʼs disease
- (2008) Veera Hölttä et al. INFLAMMATORY BOWEL DISEASES
- IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
- (2008) Stefan Haak et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-17 produced by Paneth cells drives TNF-induced shock
- (2008) Nozomi Takahashi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
- (2008) Yan Zheng et al. NATURE MEDICINE
- Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis
- (2007) John S. Tzartos et al. AMERICAN JOURNAL OF PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now